Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
LOS ANGELES, April 30, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Babcock & Wilcox Enterprises, (“B&W” or the "Company") (NYSE: BW) investors of a class action on behalf of...
-
LOS ANGELES, April 30, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Medpace Holdings, Inc., (“Medpace” or the "Company") (NASDAQ: MEDP) investors of a class action on behalf of investors...
-
LOS ANGELES, April 30, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Upstart Holdings, Inc., (“Upstart” or the "Company") (NASDAQ: UPST) investors of a class action on behalf of investors...
-
LOS ANGELES, April 30, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises United Homes Group, Inc., (“United Homes" or the "Company") (NASDAQ:UHG) investors that the firm has initiated an...
-
LOS ANGELES, April 30, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Stellantis N.V., (“Stellantis” or the "Company") (NYSE: STLA) investors of a class action on behalf of investors that...
-
Portnoy Law Firm Announces Class Action on Behalf of Regencell Bioscience Holdings Limited Investors
LOS ANGELES, April 30, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Regencell Bioscience Holdings Limited, (“Regencell” or the "Company") (NASDAQ: RGC) investors of a class action on behalf...
-
LOS ANGELES, April 29, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises POET Technologies, Inc., (“POET Technologies” or the "Company") (NASDAQ: POET) investors of a class action on behalf of...
-
LOS ANGELES, April 29, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Globant SA, (“Globant” or the "Company") (NYSE: GLOB) investors of a class action on behalf of investors that bought...
-
LOS ANGELES, April 29, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises zSpace, Inc., (“zSpace” or the "Company") (NASDAQ: ZSPC) investors of a class action on behalf of investors that bought...
-
ImmunityBio Inc. (NASDAQ: IBRX) Investigated for Potential Federal Securities Laws Violations